Background
The Malaysian Organisation of Pharmaceutical Industries (MOPI) was incorporated on March 6th 1981, as a company limited by guarantee, by eight local, foreign and joint venture companies involved in the manufacture of pharmaceutical products.

Raja Zainal Abidin bin Raja Haji Tachik of Raza Manufacturing Sdn Bhd was elected as MOPI's first president.

MOPI membership is open to all manufacturers of pharmaceutical products whose manufacturing facilities in Malaysia are licensed by the Drug Control Authority, Ministry of Health.

MOPI's original membership of eight has grown to the current 36. All major pharmaceutical manufacturers in the country are members of MOPI.

Main Activities

• MOPI, in co-operation with the government and other bodies, represents the interests of the pharmaceutical industry.
• Promotion and development of the pharmaceutical industry.
• Foster closer co-operation among members of the Industry.
• Facilitate and encourage the development, exchange and transfer of information and technology, domestically and internationally.
• Promote and facilitate orderly trade in life science products.

Strategic Role
The MOPI membership collectively produces about 35% of Malaysia's medicine requirements. In terms of product range, MOPI members have the capability to manufacture more than 80% of the product categories in the National Essential Drugs List of Malaysia.

To a large extent, MOPI's existence has been a medium and catalyst for the rapid development and capitalization of the local pharmaceutical industry during the last decade.

It has evolved into a modern and sophisticated sector of the Malaysian economy, one that is capable of producing a wide range of products in compliance with the WHO Code of Good Manufacturing Practice and internationally accepted pharmacopoeia standards.

MOPI has also taken on the role of training personnel in the industry in the latest technologies evolving in the industry, including training in validation procedures for processes as well as equipment and also in current Good Manufacturing Practice according to the European Pharmaceutical Inspection Convention (PIC) Code as Malaysia is a member of its Pharmaceutica Inspection Cooperation Scheme, PIC/S. http://www.picscheme.org

Having invested in high-technology machinery and equipment and formalized training, MOPI members now have the capability to manufacture a wide range of products including large and small volume injectables, novel drug delivery systems, high technology testing and analytical equipment to meet internationally accepted standards of quality assurance.

Research and development is another key area for the MOPI membership. The focus areas are product development, formulation improvement, dosage fabrication and novel drug delivery systems which are carried out either in-house or in collaboration with Universiti Sains Malaysia and other tertiary institutions in the country.

Affiliations & Representations
ASEAN Pharmaceuticals Club MOPI represents the Malaysian pharmaceutical industry in the ASEAN Pharmaceutical Industry Club, an organization which it had helped to form under the ASEAN Chambers of Commerce and Industry.

Pharmaceutical Inspection Convention (PIC) Member of Pharmaceutical Inspection Cooperation Scheme, PIC/S

Dialogues with Ministry of Health and National Pharmaceutical Control Bureau
MOPI also holds regular dialogues with the Health Ministry and the National Pharmaceutical Control Bureau to resolves issues affecting the industry.

Dialogues with Ministry of International Trade & Industry
Since 1984, MOPI has acted as representative for the Malaysian pharmaceutical industry in the annual dialogues with the Ministry of International Trade and Industry.

Dialogues with Ministry of Domestic Trade & Consumer Affairs
MOPI participates in the annual dialogue representing the industry on matters pertaining to intellectual property and consumer protection. FOB